Cancer Center A Cancer Center Designated by
the National Cancer Institute

Clinical Trials in the Category "Gastrointestinal Stromal Tumors"

Drug Intervention Trials that are Recruiting

Study Title
Principal Investigator Disease Category
Phase III, Open-Label Study of Nilotinib Versus Imatinib in GIST Patients George Albert Fisher M.D. Ph.D.
Gastrointestinal Stromal Tumors





The physicians of the Stanford Cancer Center are engaged in more than 250 clinical trials.  Contracts with some of our clinical trial sponsors prevent us from listing specific trial information on our web site. Please contact the Stanford Cancer Clinical Trials Office at 650-498-7061 for information about additional open clinical trials.

Stanford Medicine Resources:

Footer Links: